-
-
-
-
-
-
-
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026
-
-
-
-
-
-
-
Evolent Health, Inc. Announces Pricing of Oversubscribed and Upsized $145.0 Million of Convertible Senior Notes Due 2031 to Repurchase Existing Notes and Class A Common Stock
-
-
-
-
-
-
-
Evolent Health (EVH) Misses Q1 EPS by 2c
-
-
-
-
-
-
-
Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025
-
-
-
-
-
-
-
Barclays Reiterates Overweight Rating on Evolent Health (EVH)
-
-
-
-
-
-
-
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
-
-
-
-
-
-
-
Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan
-
1,197,269 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

